Pivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular Degeneration
NCT07084883
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to perform a pivotal trial of iPredict, an automated AI-based system for early diagnosis and prediction of late AMD in primary care and ophthalmology settings. Patients will be invited to participate in this study by having non-dilated photos of their eyes taken by an FDA approved fundus camera (DRSPlus from Centervue Inc., CA), at their primary care doctor's office or general ophthalmologist office. The photos will then be transmitted securely and analyzed by computer in the cloud (telemedicine features).
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Age-related Macular Degeneration (AMD)
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 50 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- iHealthScreen Inc
- Last updated on ClinicalTrials.gov
- August 28, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
New York · 1
- iHealthScreen Inc. · Richmond Hill, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.